Real-world Predictors of Early Mortality and Treatment Discontinuation in HCC Patients Treated with Atezolizumab-Bevacizumab.

Palma Fedele, Matteo Landriscina, Antonio Di Stasi, Arianna Gadaleta-Caldarola, Guido Giordano, Vincenzo Emanuele Chiuri, Mariachiara Masucci, Giulia Villano, Rosaria Martina, Federica Fumai, Giovanni Santacroce, Angelo Nacci, Antonella Licchetta, Vincenzo Dadduzio, Gennaro Gadaleta-Caldarola